showed that the dominant hormonal fragments recovered in the medium have an apparent molecular weight of -6,000, lack amino-terminal antigenic determinants, and react in assays that specifically recognize determinants in the carboxy-terminal portion of the intact hormone. Amino-terminal fragments also were detected in high concentrations, particularly after short incubation periods. Radioiodinated fragments resulting from incubation of 125I-labeled bovine parathyroid hormone with Kupffer cells had the same apparent size as fragments derived from the metabolism of unlabeled, intact hormone; when analyzed by Edman degradation, positions 34 and 37 of the intact hormone sequence were the amino-terminal amino acids of these dominant carboxy-terminal fragments. Hepatocytes did not hydrolyze the hormone. Thus, metabolism of parathyroid hormone by Kupffer cells results in the appearance of fragments in the media
A B S T R A C T Data from several laboratories indicate that hepatic mechanisms may have a distinctive role in the metabolism of intact hormone after secretion, a process that accounts, at least partly, for the heterogeneity of circulating parathyroid hormone. Accordingly, we studied the proteolysis ofintact hormone by isolated rat Kupffer cells and hepatocytes. Kupffer cells (106 cells/ml) and hepatocytes (107 cells/ml) were incubated with unlabeled and 12-I-labeled bovine parathyroid hormone at 37°C for periods ranging up to 2 h. When incubated with Kupffer cells, intact hormone disappeared with a t1/2 of 12+4 min. Radioimmunoassays using sequence-specific antisera showed that the dominant hormonal fragments recovered in the medium have an apparent molecular weight of -6,000, lack amino-terminal antigenic determinants, and react in assays that specifically recognize determinants in the carboxy-terminal portion of the intact hormone. Amino-terminal fragments also were detected in high concentrations, particularly after short incubation periods. Radioiodinated fragments resulting from incubation of 125I-labeled bovine parathyroid hormone with Kupffer cells had the same apparent size as fragments derived from the metabolism of unlabeled, intact hormone; when analyzed by Edman degradation, positions 34 and 37 of the intact hormone sequence were the amino-terminal amino acids of these dominant carboxy-terminal fragments. Hepatocytes did not hydrolyze the hormone. Thus, metabolism of parathyroid hormone by Kupffer cells results in the appearance of fragments in the media that are immunochemically indistinguishable from, and chemically identical with, those found in plasma when intact hormone is injected intravenously. This indicates that the proteolysis observed in vitro accurately reflects the metabolism of the hormone in vivo. The detection of amino-terminal fragments in concentrations nearly equal to those of carboxyterminal fragments indicates that cleavage of intact hormone is, initially, by an endopeptidase(s).
Kupffer cells may be a source from which specific protease(s) that hydrolyze parathyroid hormone can be characterized, particularly in terms of enzymic specificity and requirements for inhibition. Detailed analysis of the cellular and molecular events during incubation of parathyroid hormone with these cells may help to clarify the biologic significance of the peripheral metabolism of the hormone.
INTRODUCTION
A recent review (1) and the accompanying report summarize the many lines of evidence that point to the paramount importance of the liver in the metabolism of parathyroid hormone (PTH).1 Extraction of intact bovine PTH (bPTH) by the liver is as great as or greater than that of any other organ, and the liver also releases COOH-terminal fragments into the hepatic venous effluent both in vivo and in vitro. As we showed in the accompanying report, near-total hepatectomy results in the markedly delayed clearance of intact hormone from plasma and the virtual disappearance of COOH-terminal fragments that characteristically appear in the circulation as a result of cleavage of intravenously injected intact hormone. These unique properties of the liver, particularly the liver's role in generating and releasing COOH-terminal fragments groups of lysine residues, were prepared (3, 4) . bPTH-(1-34) was synthesized by solid-phase methods and purified (5) . Biologic activity of bPTH-(1-84) was 3,000 MRCU/ mg in the in vitro rat renal cortical adenylate cyclase assay (6) and 2,500 MRCU/mg in the in vivo chick hypercalcemia assay (7).
bPTH-(1-84) and bPTH-(1-34) were iodinated with Nal25I or Na'31I (New England Nuclear, Boston, Mass.) by modification (8) of the method of Hunter and Greenwood (9) . After iodination, hormonal preparations were purified, initially by adsorption to QUSO-G-32 (Philadelphia Quartz Co., Valley Forge, Pa.), and then gel filtered on Bio-Gel P-100 (Bio-Rad Laboratories, Richmond, Calif.) (10 The suspension then was refiltered through the silk cloth, the volume distributed in plastic conical tubes (15 ml), and centrifuged at 50 g for 2 min. The cells were harvested and resuspended in fresh incubation medium at 37°C, supplemented with 0.2% heat-inactivated bovine serum albumin (Armour Pharmaceutical Co., Phoenix, Ariz.) to final hepatocyte and Kupffer-cell concentrations of 107 and 106 cells/ml, respectively. Cell preparations were evaluated by exclusion of trypan blue. Experiments were not initiated unless >90% of the hepatocytes excluded the dye and were not considered valid unless >80% of the hepatocytes excluded the dye at the end of the incubation. We, like Wincek et al. (13) , found that -80% of the Kupffer cells were stained with trypan blue. Becauise Wincek et al. (13) were uniable to detect proteolytic activity duie to cytoplasmiic enzymes in fresh Klupffer-cell suspensions, they suggested that staining by trypan blue was probably the result of continued phagocytosis of the dye, rather than disruption of the plasma membrane.
Incubations. Suspensions ofhepatocytes and Kupffer cells (2-4 ml) were distributed into polyethylene vessels, gassed with a mixture of 95%02 and 5% CO2 and incubated in the oscillating (60 cycle/min) water bath at 37°C. After 15 min was allowed for equilibration, unlabeled bPTH (5-30 ng/ml) or 125I-bPTH (1 ng/ml) was added, and the samples were removed at intervals ranging from 0 to 120 min. In experiments in which samples were to be analyzed by Edman degradation, 125I-bPTH (6 ng/ml) was used. At designated time intervals, samples (0.2-1.0 ml) were removed from each incubation vessel and centrifuge(d at 0°C in the Brinkmann model 3200 Centrifuge (Brinkmann Instruments, Inc., Westbury, N. Y.) for 3 min. Media were then aspirated. Both pellets and media were denatured in 6 M guanidine-HCl (Heico Laboratories, Delaware Water Gap, Pa.), quick-frozen in acetone/dry ice (Airco Industrial Gases, Airco, Inc., Murray Hill, N. J.), and stored at -70°C unltil analyzed. A portion of the medium from incubations with unlabeled hormone was quick-frozen and stored without addition of guanidine for radioimmunoassay. Incubation vessels were regassed with a mixture of 95% 02 and 5% CO2 after removal of each sample.
Metabolism of 125I-labeled and unlabeled bPTH also was assessed in media without added cells and in "conditioned media." The latter were prepared by incubation of Kupffer cells in media without added hormone for 120 min at 37°C. After separation of the cells by centrifugation (10,000 g, 15 min), the media were aspirated and transferred to new vessels. The vessels were regassed with a mixture of 95% 02 and 5% CO2, and the hormonal preparations were incubated for 60 and 120 min at 37°C.
Analytic methods. All samples, except those for sequence analyses, were initially gel filtered on columns (1.2 x 100 cm) of Bio-Gel P-100 (100-200 mesh, Bio-Rad Laboratories, Richmond, Calif.) at 4°C with an eluting buffer of 0.05 M sodium barbital: 10% (vol/vol) out-dated blood-bank plasma, pH 8.6. Because the Edman reaction cannot be efficiently conducted in barbital btuffer, samples for sequence analysis were lyophilized after gel filtration on columns (1.2 x 100 cm) of Bio-Gel P-100 using 0.1 M ammonium acetate:1% (vol/ vol) blood-bank plasma, pH 5.0, as the eluting buffer. Intact 1311-bPTH, 131I-bPTH-(1-34), and Na1311, added to each sample immediately before gel filtration, served to calibrate the column. The amount of the 131I-labeled peptides added was inistufficienit to initerfere wvith the radioimmnnlwliioassay s.
Fraction size was 0.9 mil. The 1251 in each fraction was counited in a dual-channiiel spectrometer (Packard Instrument Co., Inc., Downers Grove, Ill.) with appropriate correction of 125I counts for 1311.
Automated Edman degradations were performed in a model 890 Sequencer (Beekmana Inistrumllents, Inic., Spinico Div., Palo Alto, Calif.) using a single-coupling, double-cleavage program (15) . Lyophilized samples were dissolved in heptafluorobutyric acid. All procedures used for converting the anilinothiazolinone derivatives of the amino acids and for identifying the radioiodinated derivatives were previously reported (10, 16) . All samples were degraded for at least 25 cycles. The results are expressed after correction for a repetitive yield of 93% for each cycle of the degradation; this figure represents the average yield found in eight degradations of myoglobin.
Radioimmunoassays that measure specific regions of the PTH sequence were performed, using antiserum GP-1 and nonequilibrium conditions as previously described (8, 17) .
Highly purified bPTHI was used as the standard, and, after iodination with 1251, the same preparation was used as the tracer. GP-1 recognizes two major antigenic determinants in the bPTH molecule: one that includes some or all of the 14-27 region and one that includes some or all of the 53-84 region (8, 17) . To restrict antigenic recognition to NH2-and COOH-terminal regions of the molecule, respectively, assays using GP-1 were conducted after preincubating the antiserum with an excess of either bPTH-(53-84) or bPTH-(1-34).
RESULTS
Incubations of bPTH tvith isolated hepatic cells. Samples were removed at 10, 30, 60, and 120 min after addition of intact bPTH (5-30 ng/ml) to suspensions of isolated Kupffer cells or hepatocytes. Portions of unfractionated media and fractions eluting after gel filtration of the media were assayed in NH2-and COOH-terminal specific radioimmunoassays. After incubation of the intact hormone with Kupffer cells for 10 min, the media contained 90±+7% and 85±+9% of the hormonal concentrations added initially to the incubation when measured in COOH-and NH2-terminal specific assays, respectively (Table I) the COOH-terminal immunoreactivity that had been added initially was detected, but only 20+11% and 8±7% of the NH2-terminal immunoreactivity remained after these incubation periods (Table I) . Radioimmunoassay of fractions derived from gel filtration of the media, collected after incubation of bPTH with Kupffer cells for varying time periods, confirms and extends these findings. After 10-min incubations, the fall in intact-hormone concentration is matched by nearly equal concentrations of COOHand NH2-terminal immunoreactive fragments (Fig. 1A) of 125I-labeled hormonal fragments were detected in the media. These fragments accounted for 55±15% of the radioactivity after 120 min, and they eluted at the same column volume as the immunoreactive COOH-terminal fragments. In addition, radioactivity eluting at the salt volume also increased with time and accounted for 20±10% of the 125I after 120 min (Fig. 2A) .
The media recovered after 60-min incubations with Kupffer cells were initially gel filtered, and fractions from the region of the gel profile comprising the peak of late-eluting, 125I-labeled COOH-terminal fragments were pooled, lyophilized, and degraded by the automated Edman reaction. Fig. 3 , which is representative of four experiments, shows the release of specific mono-and di-iodotyrosyl radioactivity principally at cycles 10 and 7 of the degradation. Inasmuch as the single tyrosyl residue in bPTH is located at position 43 in the intact sequence, recovery of iodotyrosyl radioactivity at these cycles is consistent with hormonal proteolysis between positions 33 and 34, and 36 and 37 of the intact sequence. Less prominent increases in release of radioactivity above background occurred at hepatocytes. The columns were calibrated as in Fig. 1 The media recovered after 60-min incubations with hepatocytes were also analyzed by sequence analysis. After the samples were gel filtered, fractions eluting from the region of the chromatogram that included a portion of the intact hormone peak and the small, late-eluting, 125I-labeled fragments were pooled, lyophilized, and degraded for 25 cycles. Quantitatively, the radioactivity released was far less than that seen when media from Kupffer cells were analyzed, but the pattern of iodotyrosyl radioactivity detected was identical. In both experiments, 125I was released principally at cycle 10 and 7; release of radioactivity above background also occurred at cycle 3 (figure not shown).
Extracts of Kupffer-cell pellets recovered between 30 and 120 min all contained 15±5% ofthe radioactivity added to the incubation. Gel filtration revealed that these cell pellets contained 125I that eluted primarily at a volume consistent with intact hormone and also contained a small amount ofboth 125I-labeled hormonal fragments and '25I that eluted at the salt volume (Fig.  4A) . The amount of 1251 in the hepatocyte pellets was approximately the same as that in the Kupffer-cell pellets, and, upon gel chromatography, the radioactivity also appeared to primarily elute at the position of intact hormone (Fig. 4B) .
In each experiment, control incubations of 125I-bPTH with media alone for 120 min did not result in the appearance of any hormonal fragments.
Incubations of 1251-labeled and unlabeled bPTH with conditioned media. Media recovered after incubations of the hormone with conditioned media were compared with media from incubations of the hormone with Kupffer cells (106 cells/ml) for the same time intervals. After gel filtration of the samples, fractions were either immunoassayed or counted for radioactivity. In two experiments with intact, unlabeled bPTH and in three experiments with 125I-labeled hormone, hormonal fragments constituted an amount that was between 3 and 15% of the amount seen when hormone was incubated in the presence of Kupffer cells for 60 min and 120 min. However, in a fourth study that appeared successful by the usual criteria, the amount of 125I-labeled fragments detected in the conditioned media after 120 min was 55% of that detected in the incubation containing cells.
DISCUSSION
The present studies are based on our observations and those of others (for review, see [1] and accompanying report) that the liver in vivo is critical in the proteolytic metabolism of PTH, once this hormone enters the circulation. The reason for searching for the hepatic cell type responsible for hormonal proteolysis derives, in part, from our finding that the characteristic metabolic fate of injected, intact bPTH is radically altered in hepatectomized rats; the concentration of COOHterminal fragments, in plasma, is very low in these animals, and no radioiodinated COOH fragments with NH2-terminal residues at position 34 or 37 could be detected in their circulation. If cells containing these specific enzymes could be identified, then characterization and, perhaps, isolation of the enzyme(s) involved would be greatly facilitated. In addition, an in vitro test system would be very useful in evaluating potential competitive antagonists ofthe cleavage process, compounds that could serve as probes to study the biologic significance of the peripheral metabolism of the hormone in vivo.
We believe that the studies reported in these two companion manuscripts represent considerable progress in the understanding of the peripheral metabolism of PTH. Studies of the proteolysis of PTH by Kupffer cells now can be pursued with considerable assurance that they are physiologically relevant to the process of hormonal metabolism in vivo, because cleavage of the hormone by these cells in vitro is chemically identical with the pattern of cleavage seen when labeled hormone is injected into the intact animal.
By Immunochemical studies using unlabeled hormone confirm the results seen with radioiodinated hormone within the limitations of the methods employed. Radioimmunoassays using sequence-specific antisera show that the dominant PTH fragments recovered in the media of Kupffercell incubations have an apparent molecular weight of -6,000, lack NH2-terminal antigenic determinants, and react in radioimmunoassays that are specific for the COOH-terminal portions of the intact hormone sequence. The fragments in these media are immunochemically indistinguishable from, and chemically identical with, those found in plasma when unlabeled and 125I-labeled bPTH are injected intravenously in rats (10) and dogs (16) . Most likely, the chemical properties ofthe metabolites ofbiologically active, intact hormone can be best defined by studying the proteolysis of biosynthetically prepared hormone that is labeled to high specific activity by incorporation of radioactive amino acids into the peptide sequence. However, the use of the radioiodinated probe has allowed us to validate our observations as we have proceeded from determinations of the fragments found in the circulation (10, 16) to those found in the liver (18) to, currently, those generated by the Kupffer cells.
Our data seem to indicate that Kupffer cells metabolize unlabeled PTH faster than they metabolize the labeled hormone. Although we cannot dismiss the possibility that the different rates of proteolysis reflect intrinsic differences in the two substrates, these discrepancies in cleavage rates are more apparent than real. When tracer amounts of 125I-bPTH are chromatographed on columns with nondenaturing buffers in the presence of carriers, particularly plasma, a significant portion of the radioactivity elutes at the void volume of the column. Studies in intact animals showed that this form of 125I-labeled hormone appears to be metabolized much more slowly than the hormone that elutes at the appropriate column volume (10, 16, 19) . The fraction of 125I-labeled hormone eluting at the void volume is apparently protein-bound, thus accounting for its persistence in the circulation. Sequence analysis of radioactive hormone eluting at the void volume of the column showed both in our earlier (16) and in these current studies that this radioactive material is intact hormone rather than fragments. Thus, this "large" form of 125I-bPTH appears to be relatively unavailable for proteolytic attack. In contrast, analysis by radioimmunoassay of fractions after gel filtration of unlabeled intact PTH indicates that only a small portion of hormone elutes at the void volume (16, 20) . The rates of metabolism of unlabeled and 125I-labeled hormone were shown to be the same in vivo only when the data were based on analysis of the fate of labeled and unlabeled hormone that elutes at the position of intact hormone after gel filtration with nondenaturing buffers (20) .
In the current studies, highest priority was given to precise chemical identification of the fragments resulting from metabolism of 125I-bPTH. As a preventive measure, therefore, samples were denatured with 6 M guanidine-HCl to preclude potential proteolysis during further processing. Subsequent gel filtration revealed little radioactivity in the void volume of the column, reflecting the effectiveness of guanidine in dissociating the 125I-bPTH attached noncovalently to the protein carrier. Chromatography in the presence of denaturing solvents, such as guanidine-HCl, seems most appropriate to protect against potential proteolysis during collection and storage of the samples, but it appears to artefactually distort the apparent rate of cleavage of the radiolabeled hormone when compared with unlabeled bPTH. We conclude, therefore, that the kinetics of PTH metabolism are best assessed from the studies of unlabeled hormone, whereas precise chemical identification of the hormone fragments requires studies with 125I-bPTH.
Certain problems also are associated with the techniques required to isolate the Kupffer cells. When bPTH is incubated with different aliquots of the same preparation of Kupffer cells, proteolysis is rapid and occurs at the same rate. However, the absolute rate of cleavage by the same number of cells varied (Table  I) , and appeared to depend on the specific cell preparation. The complex harvesting procedure required to collect Kupffer cells probably accounts for this variability and also for our observation that appreciable concentrations of fragments were detected in one of six incubations with conditioned media. We are exploring alternative techniques for (8, 16, 20) , and other laboratories have reported that, in plasma, the concentrations of NH2-terminal fragments are much lower than are those of COOH-terminal fragments (21) (22) (23) (24) . This has led to uncertainty about the nature of the enzymic process. However, our data in vitro show that the initial attack on intact PTH is by an endopeptidase(s) that generates both NH2-and COOH-terminal fragments, rather than by an exopeptidase(s) that rapidly digests the NH2-terminal portion of the molecule. NH2-terminal fragments disappear from the medium within the first hour of incubation, at least as assessed by serial radioimmunoassays. The present data do not establish whether this represents rapid proteolysis to very small peptides by endopeptidases or exopeptidases, or relatively small chemical changes in these fragments that greatly reduce their immunoreactivity or uptake by the Kupffer cells. Nonetheless, our findings are consistent with results obtained in vivo that showed high concentrations of COOH-terminal fragments but either failed to detect any (8, 16, 20) The location of the specific enzyme(s) involved in the proteolysis of PTH has not been precisely defined. The limited degradation of PTH in conditioned media indicates that the enzyme(s) involved probably are not secreted by the Kupffer cells, and the rapid rate with which intact PTH is hydrolyzed by Kupffer-cell suspensions suggests that, most likely, the protease activity is associated with cell surface. We have not excluded the possibility that the hormone may undergo intracellular metabolism accompanied by the rapid release of fragments into the extracellular space. However, the finding that the amount of 1251 in the Kupffercell pellets was relatively small and that most of the 125I in these cells appeared to be associated with intact hormone (Fig. 4A) argues against a major role for endocytosis and lysosomal degradation in this process. Our data are compatible with the results of D'Amour et al. (25) that showed fragments in the hepatic venous effluent after a single pass of the hormone through the liver, and are consistent with, but do not prove, the idea that proteolysis of PTH may be a cell-surface phenomenon.
Recently, MacGregor et al. (26) isolated an enzyme from homogenates of porcine liver that hydrolyzed bPTH in a manner similar to, but apparently not identical with, that observed with Kupffer cells. This enzyme, which was purified to homogeneity from the supernatant fraction of liver homogenates, cleaves between positions 36 and 37 of intact bPTH and has characteristics that are consistent with the known properties of cathepsin B. Cathepsin B is generally considered to be an intracellular acid hydrolase that is in highest concentration within the lysosomes and is unstable at pH 7.0 or above (27) . It is not clear whether this enzyme is involved in the proteolysis of PTH by Kupffer cells. However, it has distinctive properties that may possibly have considerable relevance; it is the only enzyme thus far reported that hydrolyzes PTH at sites consistent with those that are cleaved in vivo.
Hepatic metabolism ofPTH by the isolated, perfused rat liver was shown to release biologically active, NH2-terminal fragments into the perfusate (28) . Therefore, it is attractive to speculate that an endopeptidase(s) in Kupffer cells may generate biologically active fragments that may act locally in the liver or have preferential effects on particular target tissues. Alternatively, hormonal cleavage may be merely a catabolic process leading to inactivation of the hormone through destruction of NH2-terminal portion of the sequence. This possibility is suggested by the finding that NH2-terminal fragments rapidly disappear in vitro and are not detected in substantial concentrations in plasma in vivo.
Our studies of the metabolism of PTH by hepatectomized rats in vivo and by Kupffer cells in vitro indicate that detailed physiological and biochemical studies with Kupffer cells should provide further insight into some of the issues involving the complex metabolism of this hormone and the relationship between proteolysis of the hormone and its biologic actions. Studies in vitro using these cells also may be applied to the design of analogues that are more potent inhibitors of hormonal proteolysis than is bPTH-(28-48), a compound that effectively inhibits cleavage of PTH, but only at high concentration (29) . Potent inhibitors in vitro also may prove, upon subsequent testing, to be effective inhibitors in vivo and may be useful in studies to clarify the biological significance of the peripheral metabolism of the hormone.
